The Asia Pacific Home Healthcare Market should witness market growth of 9.3% CAGR during the forecast period (2022-2028).
In hospitals, care is often uniform and straitjacket-styled for everyone. There isn't much space left to accommodate the patient's unique needs and independence. Patients may become unhappy as a result, in one way or another. Giving patients expert treatment at home helps to individualize and tailor their experience. They are made specifically for each patient and with the patient's requirements in mind.
The patient feels considerably more at ease as a result since all of his requirements are met. The patient recovers more quickly with personalized care since it offers one-on-one treatment that also meets medical requirements. Some individuals could find it challenging to take care of themselves and carry out simple duties like cleaning, cooking, grooming, and bathing. These everyday tasks are also made easier to do with the assistance of professional in-home care.
Additionally, these experts assist with simple domestic tasks like laundry and dishwashing, which helps maintain a respectable standard of living. A home health aide is qualified to assist patients with ADLs (Activities of daily living). This promotes patients' respect, dignity, and ability to live long, healthy life. The home nurses support the patient with all of their activities.
One of the world's fastest-growing aging populations is in China. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. For public health and socioeconomic development, this profound demographic shift creates a number of new challenges and opportunities. China has been investigating cutting-edge methods for enhancing access to integrated care. For these elderly folks, this would all lead to a rise in demand for home healthcare services. As a consequence, the Asia Pacific region's home healthcare industry would experience rapid expansion.
The China market dominated the Asia Pacific Home Healthcare Market by Country in 2021; thereby, achieving a market value of $31, 124.1 million by 2028. The Japan market is registering a CAGR of 8.6% during (2022-2028). Additionally, The India market would showcase a CAGR of 9.9% during (2022-2028).
Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy and Pregnancy Care. Based on Product Type, the market is segmented into Therapeutic Products, Testing, Screening, & Monitoring Products and Mobility Care Products. Based on Indication, the market is segmented into Cancer & Other Indications, Respiratory Diseases, Wound Care, Pregnancy, Movement Disorders, Hearing Disorders, Cardiovascular Diseases & Hypertension and Diabetes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.
In hospitals, care is often uniform and straitjacket-styled for everyone. There isn't much space left to accommodate the patient's unique needs and independence. Patients may become unhappy as a result, in one way or another. Giving patients expert treatment at home helps to individualize and tailor their experience. They are made specifically for each patient and with the patient's requirements in mind.
The patient feels considerably more at ease as a result since all of his requirements are met. The patient recovers more quickly with personalized care since it offers one-on-one treatment that also meets medical requirements. Some individuals could find it challenging to take care of themselves and carry out simple duties like cleaning, cooking, grooming, and bathing. These everyday tasks are also made easier to do with the assistance of professional in-home care.
Additionally, these experts assist with simple domestic tasks like laundry and dishwashing, which helps maintain a respectable standard of living. A home health aide is qualified to assist patients with ADLs (Activities of daily living). This promotes patients' respect, dignity, and ability to live long, healthy life. The home nurses support the patient with all of their activities.
One of the world's fastest-growing aging populations is in China. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. For public health and socioeconomic development, this profound demographic shift creates a number of new challenges and opportunities. China has been investigating cutting-edge methods for enhancing access to integrated care. For these elderly folks, this would all lead to a rise in demand for home healthcare services. As a consequence, the Asia Pacific region's home healthcare industry would experience rapid expansion.
The China market dominated the Asia Pacific Home Healthcare Market by Country in 2021; thereby, achieving a market value of $31, 124.1 million by 2028. The Japan market is registering a CAGR of 8.6% during (2022-2028). Additionally, The India market would showcase a CAGR of 9.9% during (2022-2028).
Based on Type, the market is segmented into Services and Product. Based on Services Type, the market is segmented into Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy and Pregnancy Care. Based on Product Type, the market is segmented into Therapeutic Products, Testing, Screening, & Monitoring Products and Mobility Care Products. Based on Indication, the market is segmented into Cancer & Other Indications, Respiratory Diseases, Wound Care, Pregnancy, Movement Disorders, Hearing Disorders, Cardiovascular Diseases & Hypertension and Diabetes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amedisys, Inc., LHC Group, Inc., ResMed, Inc., Omron Corporation, Abbott Laboratories, Invacare Corporation, Linde PLC, A&D HOLON Holdings Company, Limited, Fresenius SE & Co. KGaA and F. Hoffmann-La Roche Ltd.
Scope of the Study
By Type
- Services
- Skilled Nursing
- Rehabilitation Therapy
- Hospice & Palliative Care
- Unskilled Care
- Respiratory Therapy
- Infusion Therapy
- Pregnancy Care
- Product
- Therapeutic Products
- Testing, Screening, & Monitoring Products
- Mobility Care Products
By Indication
- Cancer & Other Indications
- Respiratory Diseases
- Wound Care
- Pregnancy
- Movement Disorders
- Hearing Disorders
- Cardiovascular Diseases & Hypertension
- Diabetes
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Amedisys, Inc.
- LHC Group, Inc.
- ResMed, Inc.
- Omron Corporation
- Abbott Laboratories
- Invacare Corporation
- Linde PLC
- A&D HOLON Holdings Company, Limited
- Fresenius SE & Co. KGaA
- F.Hoffmann-La Roche Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Home Healthcare Market, by Type
1.4.2 Asia Pacific Home Healthcare Market, by Indication
1.4.3 Asia Pacific Home Healthcare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Home Healthcare Market
Chapter 4. Asia Pacific Home Healthcare Market by Type
4.1 Asia Pacific Services Market by Country
4.2 Asia Pacific Home Healthcare Market by Services Type
4.2.1 Asia Pacific Skilled Nursing Market by Country
4.2.2 Asia Pacific Rehabilitation Therapy Market by Country
4.2.3 Asia Pacific Hospice & Palliative Care Market by Country
4.2.4 Asia Pacific Unskilled Care Market by Country
4.2.5 Asia Pacific Respiratory Therapy Market by Country
4.2.6 Asia Pacific Infusion Therapy Market by Country
4.2.7 Asia Pacific Pregnancy Care Market by Country
4.3 Asia Pacific Product Market by Country
4.4 Asia Pacific Home Healthcare Market by Product Type
4.4.1 Asia Pacific Therapeutic Products Market by Country
4.4.2 Asia Pacific Testing, Screening, & Monitoring Products Market by Country
4.4.3 Asia Pacific Mobility Care Products Market by Country
Chapter 5. Asia Pacific Home Healthcare Market by Indication
5.1 Asia Pacific Cancer & Other Indications Market by Country
5.2 Asia Pacific Respiratory Diseases Market by Country
5.3 Asia Pacific Wound Care Market by Country
5.4 Asia Pacific Pregnancy Market by Country
5.5 Asia Pacific Movement Disorders Market by Country
5.6 Asia Pacific Hearing Disorders Market by Country
5.7 Asia Pacific Cardiovascular Diseases & Hypertension Market by Country
5.8 Asia Pacific Diabetes Market by Country
Chapter 6. Asia Pacific Home Healthcare Market by Country
6.1 China Home Healthcare Market
6.1.1 China Home Healthcare Market by Type
6.1.1.1 China Home Healthcare Market by Services Type
6.1.1.2 China Home Healthcare Market by Product Type
6.1.2 China Home Healthcare Market by Indication
6.2 Japan Home Healthcare Market
6.2.1 Japan Home Healthcare Market by Type
6.2.1.1 Japan Home Healthcare Market by Services Type
6.2.1.2 Japan Home Healthcare Market by Product Type
6.2.2 Japan Home Healthcare Market by Indication
6.3 India Home Healthcare Market
6.3.1 India Home Healthcare Market by Type
6.3.1.1 India Home Healthcare Market by Services Type
6.3.1.2 India Home Healthcare Market by Product Type
6.3.2 India Home Healthcare Market by Indication
6.4 South Korea Home Healthcare Market
6.4.1 South Korea Home Healthcare Market by Type
6.4.1.1 South Korea Home Healthcare Market by Services Type
6.4.1.2 South Korea Home Healthcare Market by Product Type
6.4.2 South Korea Home Healthcare Market by Indication
6.5 Singapore Home Healthcare Market
6.5.1 Singapore Home Healthcare Market by Type
6.5.1.1 Singapore Home Healthcare Market by Services Type
6.5.1.2 Singapore Home Healthcare Market by Product Type
6.5.2 Singapore Home Healthcare Market by Indication
6.6 Malaysia Home Healthcare Market
6.6.1 Malaysia Home Healthcare Market by Type
6.6.1.1 Malaysia Home Healthcare Market by Services Type
6.6.1.2 Malaysia Home Healthcare Market by Product Type
6.6.2 Malaysia Home Healthcare Market by Indication
6.7 Rest of Asia Pacific Home Healthcare Market
6.7.1 Rest of Asia Pacific Home Healthcare Market by Type
6.7.1.1 Rest of Asia Pacific Home Healthcare Market by Services Type
6.7.1.2 Rest of Asia Pacific Home Healthcare Market by Product Type
6.7.2 Rest of Asia Pacific Home Healthcare Market by Indication
Chapter 7. Company Profiles
7.1 Amedisys, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Acquisition and Mergers:
7.2 LHC Group, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Partnerships, Collaborations, and Agreements:
7.2.4.2 Acquisition and Mergers:
7.3 ResMed, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Omron Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Invacare Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Linde PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 A&D HOLON Holdings Company, Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.9 Fresenius SE & Co. KGaA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. F. Hoffmann-La Roche Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Companies Mentioned
- Amedisys, Inc.
- LHC Group, Inc.
- ResMed, Inc.
- Omron Corporation
- Abbott Laboratories
- Invacare Corporation
- Linde PLC
- A&D HOLON Holdings Company, Limited
- Fresenius SE & Co. KGaA
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
